3rd Quarter - Report

WELSH ROSE, LLC for U.S. RENAL CARE

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Dialysis reimbursement issues and issues related to the Medicare Secondary Payer program. H.R. 6214, Kidney Care Access Protection Act.

LobbyistCovered position, as disclosed
KATE ROSE —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 6214 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.